(Teleborsa) - Laboratorio Farmaceutico Erfo, a company active in the nutraceutic sector listed on Euronext Growth Milan, closed the first nine months of 2026 with consolidated revenues of 7.4 million euros,...
This story is only covered by news sources that have yet to be evaluated by the independent media monitoring agencies we use to assess the quality and reliability of news outlets on our platform. Learn more here.
(Teleborsa) - Laboratorio Farmaceutico Erfo, a company active in the nutraceutic sector listed on Euronext Growth Milan, closed the first nine months of 2026 with consolidated revenues of 7.4 million euros,...